Working… Menu
Trial record 2 of 2 for:    cd07223

Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01670032
Recruitment Status : Completed
First Posted : August 21, 2012
Last Update Posted : August 12, 2014
Information provided by (Responsible Party):
NovaBay Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2013
Actual Study Completion Date : August 2013
Certification/Extension First Submitted : August 7, 2014